Encompass Health Corporation (EHC)
NYSE: EHC · IEX Real-Time Price · USD
85.83
+0.38 (0.44%)
May 20, 2024, 11:05 AM EDT - Market open
Encompass Health Stock Forecast
Stock Price Forecast
The 8 analysts with 12-month price forecasts for Encompass Health stock have an average target of 87.75, with a low estimate of 70 and a high estimate of 108. The average target predicts an increase of 2.24% from the current stock price of 85.83.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for EHC stock from 8 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Dec '23 | Jan '24 | Feb '24 | Mar '24 | Apr '24 | May '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 5 | 5 | 5 | 5 | 5 | 3 |
| Buy | 4 | 4 | 4 | 4 | 4 | 4 |
| Hold | 2 | 2 | 2 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 11 | 11 | 11 | 10 | 10 | 8 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Raymond James | Raymond James | Strong Buy Reiterates $85 → $95 | Strong Buy | Reiterates | $85 → $95 | +10.68% | Apr 26, 2024 |
| Barclays | Barclays | Buy Maintains $101 → $108 | Buy | Maintains | $101 → $108 | +25.83% | Apr 25, 2024 |
| Mizuho | Mizuho | Strong Buy Maintains $93 → $95 | Strong Buy | Maintains | $93 → $95 | +10.68% | Apr 25, 2024 |
| Barclays | Barclays | Buy Maintains $95 → $101 | Buy | Maintains | $95 → $101 | +17.67% | Mar 28, 2024 |
| Barclays | Barclays | Buy Initiates $95 | Buy | Initiates | $95 | +10.68% | Mar 6, 2024 |
Financial Forecast
Revenue This Year
5.31B
from 4.80B
Increased by 10.66%
Revenue Next Year
5.77B
from 5.31B
Increased by 8.53%
EPS This Year
4.00
from 3.47
Increased by 15.39%
EPS Next Year
4.44
from 4.00
Increased by 10.91%
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | 5.6B | 6.1B | 6.6B |
| Avg | 5.3B | 5.8B | 6.3B |
| Low | 5.1B | 5.5B | 6.0B |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | 16.0% | 14.5% | 15.1% |
| Avg | 10.7% | 8.5% | 9.0% |
| Low | 6.9% | 4.3% | 4.2% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | 4.23 | 4.85 | 5.60 |
| Avg | 4.00 | 4.44 | 5.04 |
| Low | 3.83 | 4.14 | 4.70 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | 21.9% | 21.1% | 26.0% |
| Avg | 15.4% | 10.9% | 13.6% |
| Low | 10.4% | 3.3% | 5.9% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.